InVitria receives $1.5 million grant for cell-based vaccines

FORT COLLINS - InVitria, a division of Ventria Bioscience, announced it will receive $1.5 million over two years to develop a novel, animal-free, defined cell culture media for the commercial... Read More

By: Jay Jacoby Wednesday May 30, 2012 0 comments Tags: cell-based vaccines, InVitria, Scott Deeter, Ventria Bioscience